IP Library › Assignment 055694/0001
Patent Assignment
Reel/Frame 055694/0001

Assignment of Assignor's Interest

Recorded: 2021-03-23 Pages: 62
Assignor
SAMUMED, LLC
Executed: 2021-03-05
Assignee
BIOSPLICE THERAPEUTICS, INC.
9360 TOWNE CENTRE DRIVE, SAN DIEGO, CALIFORNIA, 92121
Covered Properties (50)
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/130,842 →
Publication: US US20190233396A1
3-(3H-Imidazo[4,5-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridine and Therapeutic Uses Thereof
Application: 16/162,155 →
Publication: US US20190119303A1
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/164,447 →
Publication: US US20190119263A1
6-(6-Membered Heteroaryl & Aryl)Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/172,553 →
Publication: US US20190125740A1
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof
Application: 16/172,589 →
Publication: US US20190125741A1
Diazanaphthalen-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/177,149 →
Publication: US US20190127370A1
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
Application: 16/252,055 →
Publication: US US20190352279A1
5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Application: 16/283,366 →
Publication: US US20190263821A1
Indazole Containing Macrocycles and Therapeutic Uses Thereof
Application: 16/440,284 →
Publication: US US20190382402A1
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Application: 16/518,337 →
Publication: US US20200190082A1
6-(5-Membered Heteroaryl)Isoquinolin-3-Yl-(5-Membered Heteroaryl) Carboxamides and Preparation and Use Thereof
Application: 16/528,023 →
Publication: US US20200155540A1
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
Application: 16/534,455 →
Publication: US US20200222295A1
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Application: 16/576,308 →
Publication: US US20200239436A1
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
Application: 16/577,592 →
Publication: US US20200223834A1
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/703,321 →
Publication: US US20200299263A1
Treatment of Osteoarthritis
Application: 16/710,099 →
Publication: US US20200325133A1
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 16/727,053 →
Publication: US US20200339536A1
Process for Preparing N-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Indazol-5-Yl)Pyridin-3-Yl)-3-Methylbutanamide
Application: 16/813,021 →
Publication: US US20210002273A1
Methods of Using Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Application: 16/915,316 →
Publication: US US20210121448A1
Single-Dose, Ready-to-Use Injectable Formulations
Application: 16/939,713 →
Publication: US US20210145807A1
Treatment of Osteoarthritis
Application: 17/108,544 →
Publication: US 2021/0292318
2-(1H-Indazol-3-Yl)-3H-Imidazo[4,5-C]Pyridines and Their Anti-Inflammatory Uses Thereof
Application: 17/112,282 →
Publication: US US20210292319A1
ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS
Application: 17/113,895 →
Publication: US US20210353604A1
5-Heteroaryl Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Application: 17/138,098 →
Publication: US US20220402921A1
Isoquinolin-3-Yl Carboxamides and Preparation and Use Thereof
Application: 17/155,577 →
Publication: US US20220332698A1
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
Application: 17/168,747 →
Publication: US US20230013144A1
Methods of Treating Cancer Using a Clk Inhibitor
Application: 17/254,352 →
Publication: US US20220062240A1
Solid Forms of 1-(5-(3-(7-(3-Fluorophenyl)-3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridin-5-Yl)Pyridin-3-Yl)-N,N-Dimethylmethanamine
Application: 62/979,462 →
Methods for Identifying Compounds That Modulate Wnt Signaling in Cancer Cells
Indazoles as Wnt/B-Catenin Signaling Pathway Inhibitors and Therapeutic Uses Thereof
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
B- and Y -Diketones and Y -Hydroxyketones as Wnt/ B -Catenin Signaling Pathway Activators
Indazole-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors
Indazole Inhibitors of the Wnt Signal Pathway and Therapeutic Uses Thereof
1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(Benzoimidazol-2-Yl)-Indazole Inhibitors of the Wnt Signaling Pathway and Therapeutic Uses Thereof
Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators
5-Substituted Indazole-3-Carboxamides and Preparation and Use Thereof
Gamma-Diketones for Treatment and Prevention of Aging Skin and Wrinkles
3-(1H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-B]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[2,3-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-C]Pyridines and Therapeutic Uses Thereof
3-(1H-Indol-2-Yl)-1H-Indazoles and Therapeutic Uses Thereof
3-(1H-Pyrrolo[3,2-C]Pyridin-2-Yl)-1H-Pyrazolo[3,4-B]Pyridines and Therapeutic Uses Thereof
3-(3H-Imidazo[4,5-C]Pyridin-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
3-(1H-Benzo[D]Imidazol-2-Yl)-1H-Pyrazolo[4,3-B]Pyridines and Therapeutic Uses Thereof
Related Assignments (21)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 11, 2018
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 047132/0118 →
Assignment of Assignor's Interest Apr 4, 2019
From: KC, SUNIL KUMAR; MITTAPALLI, GOPI KUMAR; CHIRUTA, CHANDRAMOULI; HOFILENA, BRIAN JOSEPH
To: SAMUMED, LLC
Reel/Frame 048799/0633 →
Assignment of Assignor's Interest Apr 4, 2019
From: KC, SUNIL KUMAR; MAK, CHI CHING; CAO, JIANGUO; BOLLU, VENKATAIAH
To: SAMUMED, LLC
Reel/Frame 048799/0615 →
Assignment of Assignor's Interest Apr 4, 2019
From: KC, SUNIL KUMAR; MAK, CHI CHING; MITTAPALLI, GOPI KUMAR; HOFILENA, BRIAN JOSEPH
To: SAMUMED, LLC
Reel/Frame 048799/0549 →
Assignment of Assignor's Interest Apr 8, 2019
From: KC, SUNIL KUMAR; MAK, CHI CHING; HOFILENA, BRIAN JOSEPH; MITTAPALLI, GOPI KUMAR
To: SAMUMED, LLC
Reel/Frame 048824/0545 →
Assignment of Assignor's Interest Apr 8, 2019
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 048824/0487 →
Assignment of Assignor's Interest Jun 17, 2019
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; CAO, JIANGUO; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 049488/0212 →
Assignment of Assignor's Interest Jun 17, 2019
From: KC, SUNIL KUMAR; HOOD, JOHN
To: SAMUMED, LLC
Reel/Frame 049487/0467 →
Assignment of Assignor's Interest Aug 9, 2019
From: HOOD, JOHN; KC, SUNIL KUMAR; KIBAR, OSMAN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 050014/0713 →
Assignment of Assignor's Interest Aug 9, 2019
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 050014/0536 →
Assignment of Assignor's Interest Aug 9, 2019
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 050014/0838 →
Assignment of Assignor's Interest Jan 7, 2020
From: HOOD, JOHN; KC, SUNIL KUMAR
To: SAMUMED, LLC
Reel/Frame 051434/0783 →
Assignment of Assignor's Interest Jan 7, 2020
From: KC, SUNIL KUMAR; WALLACE, DAVID MARK; HOOD, JOHN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 051435/0096 →
Assignment of Assignor's Interest Jan 7, 2020
From: HOOD, JOHN; WALLACE, DAVID MARK; KC, SUNIL KUMAR; YAZICI, YUSUF
To: SAMUMED, LLC
Reel/Frame 051435/0391 →
Assignment of Assignor's Interest Feb 26, 2020
From: KC, SUNIL KUMAR; HOFILENA, BRIAN JOSEPH; MITTAPALLI, GOPI KUMAR; CHIRUTA, CHANDRAMOULI
To: SAMUMED, LLC
Reel/Frame 051937/0047 →
Assignment of Assignor's Interest Feb 26, 2020
From: KC, SUNIL KUMAR; MAK, CHI CHING; EASTMAN, BRIAN WALTER; CAO, JIANGUO
To: SAMUMED, LLC
Reel/Frame 051936/0754 →
Assignment of Assignor's Interest Feb 26, 2020
From: KC, SUNIL KUMAR; MITTAPALLI, GOPI KUMAR; HOFILENA, BRIAN JOSEPH; MARAKOVITS, JOSEPH TIMOTHY
To: SAMUMED, LLC
Reel/Frame 051936/0657 →
Assignment of Assignor's Interest Feb 23, 2021
From: HOOD, JOHN; WALLACE, DAVID MARK; KUMAR KC, SUNIL
To: SAMUMED, LLC
Reel/Frame 055375/0764 →
Security Interest Sep 14, 2022
From: BIOSPLICE THERAPEUTICS, INC.
To: VICKERS VENTURE FUND VI PTE. LTD.; VICKERS VENTURE FUND VI (PLAN) PTE. LTD.; VICKERS-SPLICE CO-INVESTMENT LLC; MED-PATHWAYS II LIMITED
Reel/Frame 061433/0786 →
Release of Security Interest Mar 12, 2026
From: TMF GROUP NEW YORK, LLC, NOT INDIVIDUALLY BUT SOLELY AS COLLATERAL AGENT
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 075109/0434 →
Assignment of Assignor's Interest Mar 27, 2026
From: BIOSPLICE THERAPEUTICS, INC.
To: TENARX, INC.
Reel/Frame 074209/0693 →